DexCom, Inc. (DXCM)
76.88
+4.02
(+5.52%)
USD |
NASDAQ |
Jun 08, 13:00
DexCom Market Cap : 29.67B for June 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Insulet Corp. | 10.51B |
| Abbott Laboratories | 157.55B |
| Globus Medical, Inc. | 10.78B |
| Baxter International, Inc. | 10.01B |
| Boston Scientific Corp. | 72.49B |
Market Cap Related Metrics
| PE Ratio | 32.88 |
| PS Ratio | 6.415 |
| PEG Ratio | 0.4354 |
| Price to Book Value | 10.03 |
| Price to Free Cash Flow | 21.62 |
| Price | 76.88 |
| Earnings Yield | 3.04% |
| PEGY Ratio | 0.4354 |
| Operating PE Ratio | 29.91 |
| Normalized PE Ratio | 32.88 |